资讯

Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...
Employees enrolled in HDHPs are often the most exposed to price volatility, making pharmacy strategy a critical lever in any cost-containment plan.
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
Keystone Folding Box Co. and Med-Con Technologies have partnered to integrate Med-Con's digital adherence monitoring ...
A new study from Finland has found that children with attention-deficit/hyperactivity disorder often stay on medication for ...
Keystone Folding Box Co., a provider of paperboard packaging solutions, has partnered with Med-Con Technologies, a provider ...
This study aimed to determine whether coaching or smartphone reminder interventions could reduce all-cause hospital re-admission within six months of randomization, medication adherence to ...
Medical experts found that patients who take certain antidepressants have a greater chance of gaining more weight than those ...
Of the 102,166 GLP-1s analyzed, 94% had some form of commercial insurance, yet cost-saving options were still widely overlooked.
Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says ...
After three years, only about 1 in 12 individuals taking GLP-1s to treat obesity remained on the therapy, according to a Prime Therapeutics study published on June 25. Prime is owned by 19 Blue Cross ...